Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.38 |
| ▸ | SLC5A1 | P13866 | 3/20 | 0.36 |
| ▸ | SLC5A2 | P31639 | 3/20 | 0.36 |
| ▸ | PYGB | P11216 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16010800 | 1.00 | TYR (0.38) | TYRSLC5A1SLC5A2PYGB | |
| SCHEMBL14844148 | 1.00 | TYR (0.38) | TYRSLC5A1SLC5A2PYGB | |
| SCHEMBL3661393 | 0.85 | SLC5A2 (0.38) | TYRSLC5A2 | |
| SCHEMBL14843742 | 0.80 | CYP1A2 (0.41) | — | |
| SCHEMBL14843740 | 0.80 | CYP1A2 (0.41) | — | |
| SCHEMBL16010795 | 0.80 | CYP1A2 (0.41) | — | |
| SCHEMBL14843508 | 0.79 | TDP1 (0.33) | — | |
| SCHEMBL9436437 | 0.77 | TYR (0.46) | TYRSLC5A1SLC5A2 | |
| SCHEMBL22493076 | 0.77 | CDK1 (0.40) | TYRSLC5A1SLC5A2PYGB | |
| SCHEMBL14975889 | 0.77 | CDK1 (0.40) | TYRSLC5A1SLC5A2PYGB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140256924-A1 | CARBOHYDRATE FUNCTIONALISED SURFACES | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS AND THE OTHER MEMBERS OF BOARD OF (IE) | 2014-09-11 | — | — | US | disclosed |
| EP-2748606-A1 | CARBOHYDRATE FUNCTIONALISED SURFACES | The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth (IE) | 2014-07-02 | — | — | EP | disclosed |
| WO-2013050554-A1 | CARBOHYDRATE FUNCTIONALISED SURFACES | THE PROVOST, FELLOWS, FOUNDATION SCHOLARS, AND THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN (IE) | 2013-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256924-A1 | CARBOHYDRATE FUNCTIONALISED SURFACES | CD2, CD47, CD22 | TYR 1663/4885SLC5A1 255/4885SLC5A2 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.